Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival

Although pancreatic ductal adenocarcinoma (PDAC) survival is poor, there are differences in patients’ response to the treatments. Detection of predictive biomarkers explaining these differences is of the utmost importance. In a recent study two genetic markers (CD44-rs353630 and CHI3L2-rs684559) wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentiluomo, Manuel, Corradi, Chiara, Vanella, Giuseppe, Johansen, Astrid Z., Strobel, Oliver, Szentesi, Andrea, Milanetto, Anna Caterina, Hegyi, Péter, Kupcinskas, Juozas, Tavano, Francesca, Neoptolemos, John P., Bozzato, Dania, Hackert, Thilo, Pezzilli, Raffaele, Johansen, Julia S., Costello, Eithne, Mohelnikova-Duchonova, Beatrice, van Eijck, Casper H. J., Talar-Wojnarowska, Renata, Hansen, Carsten Palnæs, Darvasi, Erika, Chen, Inna M., Cavestro, Giulia Martina, Soucek, Pavel, Piredda, Liliana, Vodicka, Pavel, Gazouli, Maria, Arcidiacono, Paolo Giorgio, Canzian, Federico, Campa, Daniele, Capurso, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027406/
https://www.ncbi.nlm.nih.gov/pubmed/33828170
http://dx.doi.org/10.1038/s41598-021-87130-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027406/
https://www.ncbi.nlm.nih.gov/pubmed/33828170
http://dx.doi.org/10.1038/s41598-021-87130-0

Ejemplares similares